Supportive Treatment
Fertivor provides supportive treatment for:
- Clomid
- Letrozole
- Femara
- Provera
- Metformin
- Depo Provera
- Fertomid
- Fertab
- Hexal MPA
- Glucophase
Fertivor can be taken with estrogen suppressing medication containing ovulation inducing medicine. Studies have shown that the ingredients contained in Fertivor can assist in promoting a healthy uterine lining. Ovulation inducing medicine has shown to cause thinning in the female uterine lining and to create a hostile environment for sperm.
Numerous studies have shown that ovulation inducing medicine can cause a decreases cervical mucus volume and quality. This means that:
- Women taking ovulation inducing medicine are much more likely to have ”hostile” cervical mucus – which provide a barrier to sperm transport and may not provide the protective shield that fertile cervical mucus provides.
- Women on ovulation inducing medicine have increased vaginal dryness – again, subverting fertility and causing discomfort during sex.
Fertivor also assists in the production and thinning of cervical mucus as promotes alkalinity in cervical mucus.
Recent studies have shown that a combination of ovulation inducing medicine and N Acetyl L Cysteine (NAC), an active ingredient in Fertivor, considerably increased both ovulation and pregnancy rates in women with ovulation inducing medicine resistant PCOS. NAC has multiple biological effects, two of which are potentially and directly related to pregnancy rate improvement. NAC has mucolytic action; thus, it can revoke the negative effect of ovulation inducing medicine on cervical mucus. Simultaneously, it has insulin sensitizing effect that could assist in issues related to PCOS. The negative influence of ovulation inducing medicine on cervical mucus can create a ”hostile” environment for conception.
In short therefore these studies have shown that NAC may:
- Revoke the negative effect of ovulation inducing medicine on cervical mucus;
- Have an insulin sensitizing effect that could assist in issues related to PCOS.
Source: Effect of N-acetyl-cysteine after ovarian drilling in clomiphene citrate-resistant PCOS women: a pilot study.Nasr A, Reprod Biomed Online. 2010 Mar; 20(3):403-9
Youssef G, Meguid Ali A, Alaa N, Makin B, Waly M, AbouSetta A. N-acetyl-cysteine in anovulatory women: the impact of postcoital test. Middle East Fertil Soc J. 2006; 11:109-112.
